Early progress on accelerating drug development with Claude

Anthropic's life sciences team has partnered with six organizations and started their own drug discovery efforts using their AI model, Claude, to accelerate drug development, identifying potential bottlenecks in the process and improving the model for future use. The team is working on various tasks such as identifying targets, designing molecules, optimizing manufacturing, and drafting regulatory filings. They are focusing on a wide range of disease areas and stages of development to understand the strengths and limitations of Claude in different tasks.